GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioTime Inc (AMEX:BTX.WS) » Definitions » Current Deferred Revenue

BioTime (BioTime) Current Deferred Revenue : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTime Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

BioTime's current deferred revenue for the quarter that ended in . 20 was $0.00 Mil.

BioTime Current Deferred Revenue Historical Data

The historical data trend for BioTime's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTime Current Deferred Revenue Chart

BioTime Annual Data
Trend
Current Deferred Revenue

BioTime Quarterly Data
Current Deferred Revenue

BioTime Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of BioTime's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTime (BioTime) Business Description

Traded in Other Exchanges
N/A
Address
Website

BioTime (BioTime) Headlines

No Headlines